What is the clinical evidence from this study?

Study design: Other. Population: Cardiometabolic syndrome (n=2). Intervention: Tirzepatide. Primary outcome: Cardiac functionality and cardiometabolic responses.

What type of study is this?

This is a Quantitative Study study (also classified as: Experimental Study).

October 9, 2025Circulation Research

Abstract Thu015: Maturation of iPSC-derived cardiomyocytes is necessary for Incretin-based analog function

View Full Paper

Ask AI

Bookmark

Key result

Tirzepatide enhances cardiac function and upregulates key metabolic genes in iPSC-derived cardiomyocytes.

Population

Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) derived from two healthy Caucasian donors

Design

Preclinical

Authors

SBstefanie banaheneStanford University PZPeter James ZushinStanford University CJCody JuguilonCardiovascular Institute of the South

Discussion

Member takes

Implication

Tirzepatide enhances cardiac functionality and metabolic gene expression in mature iPSC-derived cardiomyocytes under metabolic stress.

Key Points

Mature iPSC-derived cardiomyocytes demonstrated improved functionality after treatment with Tirzepatide.
Functional properties such as fatty acid uptake and ATP generation were similar to those in murine models.
Immunofluorescence staining showed enhanced sarcomere organization and mitochondrial density in mature cells.
Further proteomic assessments are needed to validate the cellular mechanisms behind these observations.

Structured PICO

Population

In vitro study utilizing induced pluripotent stem cell-derived cardiomyocytes from two healthy Caucasian donors to assess the effects of Tirzepatide.

Intervention

Tirzepatide in combination with a metabolic stress cocktail

Outcome

Cellular mechanisms underlying cardioprotective effects, including sarcomere fiber organization, mitochondrial density, contractile properties, and molecular changessurrogate

Tirzepatide enhances cardiac functionality and metabolic gene expression in mature iPSC-derived cardiomyocytes under metabolic stress.

Cite This Study

banahene et al. (2025) studied Cardiometabolic syndrome (n=2). Tirzepatide was evaluated on Cardiac functionality and cardiometabolic responses. Treatment with Tirzepatide enhanced cardiac functionality and upregulated key metabolic genes in mature iPSC-derived cardiomyocytes.

synapsesocial.com/papers/68e77f09d1c187e1c108fc10 https://doi.org/10.1161/res.137.suppl_1.thu015

View Full Paper

Ask AI

Bookmark

Abstract Thu015: Maturation of iPSC-derived cardiomyocytes is necessary for Incretin-based analog function

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Abstract Thu015: Maturation of iPSC-derived cardiomyocytes is necessary for Incretin-based analog function

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider